KKR Income Opportunities Fund KIO
9.89 USD -0.13 (-1.30%)
Nov 5, 2026, 11:24 AM EST
9.86 Day range 10.08
9.70 52-week range 12.12
- YTD
- -14.67%
- 1 year
- -17.24%
- Market cap
- 405.34M
- EPS (ttm)
- 0.98
- Shares out
- 27.12M
- P/E ratio
- 10.09
- Dividend
- 1.46
- Ex-dividend date
- Nov 7, 2023
- YTD return
- -14.67%
- 1-year return
- -17.24%
- Volume
- 177.76K
- Avg volume
- 248.57K
- Open
- 10.02
- Previous close
- 10.02
- Day's range
- 9.86 – 10.08
- 52-week range
- 9.70 – 12.12
2Y -3.85 (-28.00%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 12.96%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 13.70
- 200-day average
- 13.81
Next earnings
Consensus EPS estimate 0.00.
About KKR Income Opportunities Fund
KKR Income Opportunities Fund is a close ended fixed income mutual fund launched by Kohlberg Kravis Roberts & Co. L.P. The fund is managed by KKR Asset Management LLC. It invests in fixed income markets and hedging markets across the globe. The fund primarily invests in first- and second-lien secured loans, unsecured loans and high yield corporate debt instruments. It employs fundamental analysis, with a focus on dynamic hedging strategies to create its portfolio. KKR Income Opportunities Fund was formed on March 17, 2011 and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
KIO: Upgrading To 'Hold' As CCC Credit Stress Reaches Historic Levels 
CEF Weekly Review: Weakness In CCCs 
KKR Income Opportunities Fund (NYSE:KIO) Stock Short Interest Declines 75.2% 
KKR Income Opportunities Fund Declares Monthly Distributions of $0.1215 Per Share 
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation 
KKR Income Opportunities Fund (NYSE:KIO) Shares Cross Below Two Hundred Day Moving Average – Here’s What Happened 
KIO: Income May Increase Going Forward, But The Distribution Is Destroying NAV 
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model 
KKR Income Opportunities Fund Declares Monthly Distributions of $0.1215 Per Share 
KIO: High Beta Fixed Income CEF With Significant Downside (Rating Downgrade)
Your note
Sign in to keep a note on KIO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAHILL MICHAEL EDWARD | Director | Conversion of Exercise of derivative security | Feb 27, 2023 | 8,250 |
| LANE JEREMIAH S | Other Executive | Conversion of Exercise of derivative security | Feb 15, 2023 | 2,666 |
| SHELDON CHRISTOPHER A | Other Executive | Conversion of Exercise of derivative security | Feb 15, 2023 | 19,992 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Morgan Stanley | 3.48% | 944,992 | 12.41M | Sep 29, 2024 |
| UBS Group AG | 2.20% | 598,259 | 7.86M | Sep 29, 2024 |
| Guggenheim Capital, LLC | 1.96% | 530,975 | 6.97M | Sep 29, 2024 |
| Advisors Asset Management, Inc. | 1.51% | 408,655 | 5.37M | Sep 29, 2024 |
| Penserra Capital Management LLC | 1.32% | 357,306 | 4.69M | Sep 29, 2024 |
| Bank of America Corporation | 1.03% | 279,358 | 3.67M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify High Income ETF | 1.31% | 356,476 | 4.68M | Sep 29, 2024 |
| ETFis Ser Tr I-Virtus Private Credit Strategy ETF | 0.23% | 61,563 | 808.32K | Jul 30, 2024 |
| LoCorr Spectrum Income Fund | 0.16% | 44,182 | 580.11K | Sep 29, 2024 |